Huseyin C Yalcin
Overview
Explore the profile of Huseyin C Yalcin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sulaiman R, Atick Faisal M, Hasan M, Chowdhury M, Bensaali F, Alnabti A, et al.
Int J Med Inform
. 2025 Feb;
197:105840.
PMID: 39965432
Background: Transcatheter aortic valve implantation (TAVI) therapy has demonstrated its clear benefits such as low invasiveness, to treat aortic stenosis. Despite associated benefits, still post-procedural complications might occur. The severity...
2.
Alnabti A, Abujalala S, Al-Hijji M, Othman K, Rafie I, Suwaidi J, et al.
Int J Cardiol
. 2025 Feb;
424:133029.
PMID: 39894314
Background: Transcatheter aortic valve implantation (TAVI) is a therapeutic modality for high-surgical-risk patients with severe aortic stenosis. This study describes the outcomes of TAVI performed in Qatar. Methods: The Qatar...
3.
Mazhar N, Islam M, Raza M, Mahin S, Islam M, Chowdhury M, et al.
Bioengineering (Basel)
. 2024 Nov;
11(11).
PMID: 39593776
A comprehensive analysis of in vitro pumps used in cardiovascular research is provided in this review, with a focus on the characteristics of generated flows and principles of flow generations....
4.
Zakaria Z, Suleiman M, Benslimane F, Al-Badr M, Sivaraman S, Korashy H, et al.
Mol Med Rep
. 2024 Sep;
30(4).
PMID: 39219269
Tyrosine kinase inhibitors (TKIs) offer targeted therapy for cancers but can cause severe cardiotoxicities. Determining their dose‑dependent impact on cardiac function is required to optimize therapy and minimize adverse effects....
5.
Dhulkifle H, Therachiyil L, Hasan M, Sayed T, Younis S, Korashy H, et al.
Mol Biol Rep
. 2024 Jul;
51(1):859.
PMID: 39066934
Background: Doxorubicin (DOX) is a potent chemotherapy widely used in treating various neoplastic diseases. However, the clinical use of DOX is limited due to its potential toxic effect on the...
6.
Cinici B, Yaba S, Kurt M, Yalcin H, Duta L, Gunduz O
Biomimetics (Basel)
. 2024 Jul;
9(7).
PMID: 39056850
The aim of this study is to provide an overview of the current state-of-the-art in the fabrication of bioceramic scaffolds for bone tissue engineering, with an emphasis on the use...
7.
Saleh A, Thanassoulas A, Aliyev E, Swann K, Naija A, Yalcin H, et al.
Biomedicines
. 2024 Jun;
12(6).
PMID: 38927390
The sperm-specific phospholipase C zeta (PLCζ) protein is widely considered as the predominant physiological stimulus for initiating the Ca release responsible for oocyte activation during mammalian fertilization. The increasing number...
8.
Naija A, Mutlu O, Khan T, Seers T, Yalcin H
BMC Biomed Eng
. 2024 Apr;
6(1):3.
PMID: 38654382
Compared to classical techniques of morphological analysis, micro-CT (μ-CT) has become an effective approach allowing rapid screening of morphological changes. In the present work, we aimed to provide an optimized...
9.
Hasan M, Zedan H, Al-Fakhroo D, Elsayed Ibrahim H, Abiib S, El-Sherbiny I, et al.
Nitric Oxide
. 2024 Feb;
144:47-57.
PMID: 38307377
Heart failure (HF) is a multifactorial, heterogeneous systemic disease that is considered one of the leading causes of death and morbidity worldwide. It is well-known that endothelial dysfunction (ED) plays...
10.
Abbas T, Parangusan H, Yalcin H, Hassan M, Zakrif L, Zandi N, et al.
Biomed Mater
. 2024 Jan;
19(2).
PMID: 38194708
Regeneration of damaged urethral tissue remains a major challenge in the field of lower urinary tract reconstruction. To address this issue, various synthetic and natural biodegradable biomaterials are currently being...